Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Gabapentin Drug Market Growth 2022-2028

  • LP 4896871
  • 120 Pages
  • March 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Gabapentin Drug will have significant change from previous year. According to our (LP Information) latest study, the global Gabapentin Drug market size is USD million in 2022 from USD 1508.5 million in 2021, with a change of % between 2021 and 2022. The global Gabapentin Drug market size will reach USD 1712.1 million in 2028, growing at a CAGR of 1.8% over the analysis period.

The United States Gabapentin Drug market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Gabapentin Drug market, reaching US$ million by the year 2028. As for the Europe Gabapentin Drug landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Gabapentin Drug players cover Pfizer, Depomed, Apotex, and Teva, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Gabapentin Drug market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

Capsule

Tablet

Oral Solution

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Postherpetic Neuralgia in Adults

Partial Onset Seizures

Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Pfizer

Depomed

Apotex

Teva

Acella Pharmaceuticals

Taro

Sun Pharmaceutical

Glenmark

Amneal Pharmaceuticals

Aurobindo Pharma

Zydus Pharmaceuticals

Hi-Tech Pharmaceuticals

Marksans Pharma

Mylan

InvaGen Pharmaceuticals

Alkem Laboratories

Tris Pharma

ACI HealthCare Limited

Jiangsu Hengrui Medicine

CSPC Ouyi Pharmaceutical

Sciegen Pharmaceuticals

Epic Pharma

Lupin Limited

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Gabapentin Drug Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Gabapentin Drug by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Gabapentin Drug by Country/Region, 2017, 2022 & 2028

2.2 Gabapentin Drug Segment by Type

2.2.1 Capsule

2.2.2 Tablet

2.2.3 Oral Solution

2.3 Gabapentin Drug Sales by Type

2.3.1 Global Gabapentin Drug Sales Market Share by Type (2017-2022)

2.3.2 Global Gabapentin Drug Revenue and Market Share by Type (2017-2022)

2.3.3 Global Gabapentin Drug Sale Price by Type (2017-2022)

2.4 Gabapentin Drug Segment by Application

2.4.1 Postherpetic Neuralgia in Adults

2.4.2 Partial Onset Seizures

2.4.3 Others

2.5 Gabapentin Drug Sales by Application

2.5.1 Global Gabapentin Drug Sale Market Share by Application (2017-2022)

2.5.2 Global Gabapentin Drug Revenue and Market Share by Application (2017-2022)

2.5.3 Global Gabapentin Drug Sale Price by Application (2017-2022)

3 Global Gabapentin Drug by Company

3.1 Global Gabapentin Drug Breakdown Data by Company

3.1.1 Global Gabapentin Drug Annual Sales by Company (2020-2022)

3.1.2 Global Gabapentin Drug Sales Market Share by Company (2020-2022)

3.2 Global Gabapentin Drug Annual Revenue by Company (2020-2022)

3.2.1 Global Gabapentin Drug Revenue by Company (2020-2022)

3.2.2 Global Gabapentin Drug Revenue Market Share by Company (2020-2022)

3.3 Global Gabapentin Drug Sale Price by Company

3.4 Key Manufacturers Gabapentin Drug Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Gabapentin Drug Product Location Distribution

3.4.2 Players Gabapentin Drug Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Gabapentin Drug by Geographic Region

4.1 World Historic Gabapentin Drug Market Size by Geographic Region (2017-2022)

4.1.1 Global Gabapentin Drug Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Gabapentin Drug Annual Revenue by Geographic Region

4.2 World Historic Gabapentin Drug Market Size by Country/Region (2017-2022)

4.2.1 Global Gabapentin Drug Annual Sales by Country/Region (2017-2022)

4.2.2 Global Gabapentin Drug Annual Revenue by Country/Region

4.3 Americas Gabapentin Drug Sales Growth

4.4 APAC Gabapentin Drug Sales Growth

4.5 Europe Gabapentin Drug Sales Growth

4.6 Middle East & Africa Gabapentin Drug Sales Growth

5 Americas

5.1 Americas Gabapentin Drug Sales by Country

5.1.1 Americas Gabapentin Drug Sales by Country (2017-2022)

5.1.2 Americas Gabapentin Drug Revenue by Country (2017-2022)

5.2 Americas Gabapentin Drug Sales by Type

5.3 Americas Gabapentin Drug Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Gabapentin Drug Sales by Region

6.1.1 APAC Gabapentin Drug Sales by Region (2017-2022)

6.1.2 APAC Gabapentin Drug Revenue by Region (2017-2022)

6.2 APAC Gabapentin Drug Sales by Type

6.3 APAC Gabapentin Drug Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Gabapentin Drug by Country

7.1.1 Europe Gabapentin Drug Sales by Country (2017-2022)

7.1.2 Europe Gabapentin Drug Revenue by Country (2017-2022)

7.2 Europe Gabapentin Drug Sales by Type

7.3 Europe Gabapentin Drug Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Gabapentin Drug by Country

8.1.1 Middle East & Africa Gabapentin Drug Sales by Country (2017-2022)

8.1.2 Middle East & Africa Gabapentin Drug Revenue by Country (2017-2022)

8.2 Middle East & Africa Gabapentin Drug Sales by Type

8.3 Middle East & Africa Gabapentin Drug Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Gabapentin Drug

10.3 Manufacturing Process Analysis of Gabapentin Drug

10.4 Industry Chain Structure of Gabapentin Drug

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Gabapentin Drug Distributors

11.3 Gabapentin Drug Customer

12 World Forecast Review for Gabapentin Drug by Geographic Region

12.1 Global Gabapentin Drug Market Size Forecast by Region

12.1.1 Global Gabapentin Drug Forecast by Region (2023-2028)

12.1.2 Global Gabapentin Drug Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Gabapentin Drug Forecast by Type

12.7 Global Gabapentin Drug Forecast by Application

13 Key Players Analysis

13.1 Pfizer

13.1.1 Pfizer Company Information

13.1.2 Pfizer Gabapentin Drug Product Offered

13.1.3 Pfizer Gabapentin Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Pfizer Main Business Overview

13.1.5 Pfizer Latest Developments

13.2 Depomed

13.2.1 Depomed Company Information

13.2.2 Depomed Gabapentin Drug Product Offered

13.2.3 Depomed Gabapentin Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Depomed Main Business Overview

13.2.5 Depomed Latest Developments

13.3 Apotex

13.3.1 Apotex Company Information

13.3.2 Apotex Gabapentin Drug Product Offered

13.3.3 Apotex Gabapentin Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Apotex Main Business Overview

13.3.5 Apotex Latest Developments

13.4 Teva

13.4.1 Teva Company Information

13.4.2 Teva Gabapentin Drug Product Offered

13.4.3 Teva Gabapentin Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Teva Main Business Overview

13.4.5 Teva Latest Developments

13.5 Acella Pharmaceuticals

13.5.1 Acella Pharmaceuticals Company Information

13.5.2 Acella Pharmaceuticals Gabapentin Drug Product Offered

13.5.3 Acella Pharmaceuticals Gabapentin Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Acella Pharmaceuticals Main Business Overview

13.5.5 Acella Pharmaceuticals Latest Developments

13.6 Taro

13.6.1 Taro Company Information

13.6.2 Taro Gabapentin Drug Product Offered

13.6.3 Taro Gabapentin Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Taro Main Business Overview

13.6.5 Taro Latest Developments

13.7 Sun Pharmaceutical

13.7.1 Sun Pharmaceutical Company Information

13.7.2 Sun Pharmaceutical Gabapentin Drug Product Offered

13.7.3 Sun Pharmaceutical Gabapentin Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Sun Pharmaceutical Main Business Overview

13.7.5 Sun Pharmaceutical Latest Developments

13.8 Glenmark

13.8.1 Glenmark Company Information

13.8.2 Glenmark Gabapentin Drug Product Offered

13.8.3 Glenmark Gabapentin Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Glenmark Main Business Overview

13.8.5 Glenmark Latest Developments

13.9 Amneal Pharmaceuticals

13.9.1 Amneal Pharmaceuticals Company Information

13.9.2 Amneal Pharmaceuticals Gabapentin Drug Product Offered

13.9.3 Amneal Pharmaceuticals Gabapentin Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Amneal Pharmaceuticals Main Business Overview

13.9.5 Amneal Pharmaceuticals Latest Developments

13.10 Aurobindo Pharma

13.10.1 Aurobindo Pharma Company Information

13.10.2 Aurobindo Pharma Gabapentin Drug Product Offered

13.10.3 Aurobindo Pharma Gabapentin Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Aurobindo Pharma Main Business Overview

13.10.5 Aurobindo Pharma Latest Developments

13.11 Zydus Pharmaceuticals

13.11.1 Zydus Pharmaceuticals Company Information

13.11.2 Zydus Pharmaceuticals Gabapentin Drug Product Offered

13.11.3 Zydus Pharmaceuticals Gabapentin Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Zydus Pharmaceuticals Main Business Overview

13.11.5 Zydus Pharmaceuticals Latest Developments

13.12 Hi-Tech Pharmaceuticals

13.12.1 Hi-Tech Pharmaceuticals Company Information

13.12.2 Hi-Tech Pharmaceuticals Gabapentin Drug Product Offered

13.12.3 Hi-Tech Pharmaceuticals Gabapentin Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Hi-Tech Pharmaceuticals Main Business Overview

13.12.5 Hi-Tech Pharmaceuticals Latest Developments

13.13 Marksans Pharma

13.13.1 Marksans Pharma Company Information

13.13.2 Marksans Pharma Gabapentin Drug Product Offered

13.13.3 Marksans Pharma Gabapentin Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Marksans Pharma Main Business Overview

13.13.5 Marksans Pharma Latest Developments

13.14 Mylan

13.14.1 Mylan Company Information

13.14.2 Mylan Gabapentin Drug Product Offered

13.14.3 Mylan Gabapentin Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 Mylan Main Business Overview

13.14.5 Mylan Latest Developments

13.15 InvaGen Pharmaceuticals

13.15.1 InvaGen Pharmaceuticals Company Information

13.15.2 InvaGen Pharmaceuticals Gabapentin Drug Product Offered

13.15.3 InvaGen Pharmaceuticals Gabapentin Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 InvaGen Pharmaceuticals Main Business Overview

13.15.5 InvaGen Pharmaceuticals Latest Developments

13.16 Alkem Laboratories

13.16.1 Alkem Laboratories Company Information

13.16.2 Alkem Laboratories Gabapentin Drug Product Offered

13.16.3 Alkem Laboratories Gabapentin Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.16.4 Alkem Laboratories Main Business Overview

13.16.5 Alkem Laboratories Latest Developments

13.17 Tris Pharma

13.17.1 Tris Pharma Company Information

13.17.2 Tris Pharma Gabapentin Drug Product Offered

13.17.3 Tris Pharma Gabapentin Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.17.4 Tris Pharma Main Business Overview

13.17.5 Tris Pharma Latest Developments

13.18 ACI HealthCare Limited

13.18.1 ACI HealthCare Limited Company Information

13.18.2 ACI HealthCare Limited Gabapentin Drug Product Offered

13.18.3 ACI HealthCare Limited Gabapentin Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.18.4 ACI HealthCare Limited Main Business Overview

13.18.5 ACI HealthCare Limited Latest Developments

13.19 Jiangsu Hengrui Medicine

13.19.1 Jiangsu Hengrui Medicine Company Information

13.19.2 Jiangsu Hengrui Medicine Gabapentin Drug Product Offered

13.19.3 Jiangsu Hengrui Medicine Gabapentin Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.19.4 Jiangsu Hengrui Medicine Main Business Overview

13.19.5 Jiangsu Hengrui Medicine Latest Developments

13.20 CSPC Ouyi Pharmaceutical

13.20.1 CSPC Ouyi Pharmaceutical Company Information

13.20.2 CSPC Ouyi Pharmaceutical Gabapentin Drug Product Offered

13.20.3 CSPC Ouyi Pharmaceutical Gabapentin Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.20.4 CSPC Ouyi Pharmaceutical Main Business Overview

13.20.5 CSPC Ouyi Pharmaceutical Latest Developments

13.21 Sciegen Pharmaceuticals

13.21.1 Sciegen Pharmaceuticals Company Information

13.21.2 Sciegen Pharmaceuticals Gabapentin Drug Product Offered

13.21.3 Sciegen Pharmaceuticals Gabapentin Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.21.4 Sciegen Pharmaceuticals Main Business Overview

13.21.5 Sciegen Pharmaceuticals Latest Developments

13.22 Epic Pharma

13.22.1 Epic Pharma Company Information

13.22.2 Epic Pharma Gabapentin Drug Product Offered

13.22.3 Epic Pharma Gabapentin Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.22.4 Epic Pharma Main Business Overview

13.22.5 Epic Pharma Latest Developments

13.23 Lupin Limited

13.23.1 Lupin Limited Company Information

13.23.2 Lupin Limited Gabapentin Drug Product Offered

13.23.3 Lupin Limited Gabapentin Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.23.4 Lupin Limited Main Business Overview

13.23.5 Lupin Limited Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Gabapentin Drug Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Gabapentin Drug Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Capsule

Table 4. Major Players of Tablet

Table 5. Major Players of Oral Solution

Table 6. Global Gabapentin Drug Sales by Type (2017-2022) & (K Units)

Table 7. Global Gabapentin Drug Sales Market Share by Type (2017-2022)

Table 8. Global Gabapentin Drug Revenue by Type (2017-2022) & ($ million)

Table 9. Global Gabapentin Drug Revenue Market Share by Type (2017-2022)

Table 10. Global Gabapentin Drug Sale Price by Type (2017-2022) & (USD/Unit)

Table 11. Global Gabapentin Drug Sales by Application (2017-2022) & (K Units)

Table 12. Global Gabapentin Drug Sales Market Share by Application (2017-2022)

Table 13. Global Gabapentin Drug Revenue by Application (2017-2022)

Table 14. Global Gabapentin Drug Revenue Market Share by Application (2017-2022)

Table 15. Global Gabapentin Drug Sale Price by Application (2017-2022) & (USD/Unit)

Table 16. Global Gabapentin Drug Sales by Company (2020-2022) & (K Units)

Table 17. Global Gabapentin Drug Sales Market Share by Company (2020-2022)

Table 18. Global Gabapentin Drug Revenue by Company (2020-2022) ($ Millions)

Table 19. Global Gabapentin Drug Revenue Market Share by Company (2020-2022)

Table 20. Global Gabapentin Drug Sale Price by Company (2020-2022) & (USD/Unit)

Table 21. Key Manufacturers Gabapentin Drug Producing Area Distribution and Sales Area

Table 22. Players Gabapentin Drug Products Offered

Table 23. Gabapentin Drug Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 24. New Products and Potential Entrants

Table 25. Mergers & Acquisitions, Expansion

Table 26. Global Gabapentin Drug Sales by Geographic Region (2017-2022) & (K Units)

Table 27. Global Gabapentin Drug Sales Market Share Geographic Region (2017-2022)

Table 28. Global Gabapentin Drug Revenue by Geographic Region (2017-2022) & ($ millions)

Table 29. Global Gabapentin Drug Revenue Market Share by Geographic Region (2017-2022)

Table 30. Global Gabapentin Drug Sales by Country/Region (2017-2022) & (K Units)

Table 31. Global Gabapentin Drug Sales Market Share by Country/Region (2017-2022)

Table 32. Global Gabapentin Drug Revenue by Country/Region (2017-2022) & ($ millions)

Table 33. Global Gabapentin Drug Revenue Market Share by Country/Region (2017-2022)

Table 34. Americas Gabapentin Drug Sales by Country (2017-2022) & (K Units)

Table 35. Americas Gabapentin Drug Sales Market Share by Country (2017-2022)

Table 36. Americas Gabapentin Drug Revenue by Country (2017-2022) & ($ Millions)

Table 37. Americas Gabapentin Drug Revenue Market Share by Country (2017-2022)

Table 38. Americas Gabapentin Drug Sales by Type (2017-2022) & (K Units)

Table 39. Americas Gabapentin Drug Sales Market Share by Type (2017-2022)

Table 40. Americas Gabapentin Drug Sales by Application (2017-2022) & (K Units)

Table 41. Americas Gabapentin Drug Sales Market Share by Application (2017-2022)

Table 42. APAC Gabapentin Drug Sales by Region (2017-2022) & (K Units)

Table 43. APAC Gabapentin Drug Sales Market Share by Region (2017-2022)

Table 44. APAC Gabapentin Drug Revenue by Region (2017-2022) & ($ Millions)

Table 45. APAC Gabapentin Drug Revenue Market Share by Region (2017-2022)

Table 46. APAC Gabapentin Drug Sales by Type (2017-2022) & (K Units)

Table 47. APAC Gabapentin Drug Sales Market Share by Type (2017-2022)

Table 48. APAC Gabapentin Drug Sales by Application (2017-2022) & (K Units)

Table 49. APAC Gabapentin Drug Sales Market Share by Application (2017-2022)

Table 50. Europe Gabapentin Drug Sales by Country (2017-2022) & (K Units)

Table 51. Europe Gabapentin Drug Sales Market Share by Country (2017-2022)

Table 52. Europe Gabapentin Drug Revenue by Country (2017-2022) & ($ Millions)

Table 53. Europe Gabapentin Drug Revenue Market Share by Country (2017-2022)

Table 54. Europe Gabapentin Drug Sales by Type (2017-2022) & (K Units)

Table 55. Europe Gabapentin Drug Sales Market Share by Type (2017-2022)

Table 56. Europe Gabapentin Drug Sales by Application (2017-2022) & (K Units)

Table 57. Europe Gabapentin Drug Sales Market Share by Application (2017-2022)

Table 58. Middle East & Africa Gabapentin Drug Sales by Country (2017-2022) & (K Units)

Table 59. Middle East & Africa Gabapentin Drug Sales Market Share by Country (2017-2022)

Table 60. Middle East & Africa Gabapentin Drug Revenue by Country (2017-2022) & ($ Millions)

Table 61. Middle East & Africa Gabapentin Drug Revenue Market Share by Country (2017-2022)

Table 62. Middle East & Africa Gabapentin Drug Sales by Type (2017-2022) & (K Units)

Table 63. Middle East & Africa Gabapentin Drug Sales Market Share by Type (2017-2022)

Table 64. Middle East & Africa Gabapentin Drug Sales by Application (2017-2022) & (K Units)

Table 65. Middle East & Africa Gabapentin Drug Sales Market Share by Application (2017-2022)

Table 66. Key Market Drivers & Growth Opportunities of Gabapentin Drug

Table 67. Key Market Challenges & Risks of Gabapentin Drug

Table 68. Key Industry Trends of Gabapentin Drug

Table 69. Gabapentin Drug Raw Material

Table 70. Key Suppliers of Raw Materials

Table 71. Gabapentin Drug Distributors List

Table 72. Gabapentin Drug Customer List

Table 73. Global Gabapentin Drug Sales Forecast by Region (2023-2028) & (K Units)

Table 74. Global Gabapentin Drug Sales Market Forecast by Region

Table 75. Global Gabapentin Drug Revenue Forecast by Region (2023-2028) & ($ millions)

Table 76. Global Gabapentin Drug Revenue Market Share Forecast by Region (2023-2028)

Table 77. Americas Gabapentin Drug Sales Forecast by Country (2023-2028) & (K Units)

Table 78. Americas Gabapentin Drug Revenue Forecast by Country (2023-2028) & ($ millions)

Table 79. APAC Gabapentin Drug Sales Forecast by Region (2023-2028) & (K Units)

Table 80. APAC Gabapentin Drug Revenue Forecast by Region (2023-2028) & ($ millions)

Table 81. Europe Gabapentin Drug Sales Forecast by Country (2023-2028) & (K Units)

Table 82. Europe Gabapentin Drug Revenue Forecast by Country (2023-2028) & ($ millions)

Table 83. Middle East & Africa Gabapentin Drug Sales Forecast by Country (2023-2028) & (K Units)

Table 84. Middle East & Africa Gabapentin Drug Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Global Gabapentin Drug Sales Forecast by Type (2023-2028) & (K Units)

Table 86. Global Gabapentin Drug Sales Market Share Forecast by Type (2023-2028)

Table 87. Global Gabapentin Drug Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 88. Global Gabapentin Drug Revenue Market Share Forecast by Type (2023-2028)

Table 89. Global Gabapentin Drug Sales Forecast by Application (2023-2028) & (K Units)

Table 90. Global Gabapentin Drug Sales Market Share Forecast by Application (2023-2028)

Table 91. Global Gabapentin Drug Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 92. Global Gabapentin Drug Revenue Market Share Forecast by Application (2023-2028)

Table 93. Pfizer Basic Information, Gabapentin Drug Manufacturing Base, Sales Area and Its Competitors

Table 94. Pfizer Gabapentin Drug Product Offered

Table 95. Pfizer Gabapentin Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 96. Pfizer Main Business

Table 97. Pfizer Latest Developments

Table 98. Depomed Basic Information, Gabapentin Drug Manufacturing Base, Sales Area and Its Competitors

Table 99. Depomed Gabapentin Drug Product Offered

Table 100. Depomed Gabapentin Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 101. Depomed Main Business

Table 102. Depomed Latest Developments

Table 103. Apotex Basic Information, Gabapentin Drug Manufacturing Base, Sales Area and Its Competitors

Table 104. Apotex Gabapentin Drug Product Offered

Table 105. Apotex Gabapentin Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 106. Apotex Main Business

Table 107. Apotex Latest Developments

Table 108. Teva Basic Information, Gabapentin Drug Manufacturing Base, Sales Area and Its Competitors

Table 109. Teva Gabapentin Drug Product Offered

Table 110. Teva Gabapentin Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 111. Teva Main Business

Table 112. Teva Latest Developments

Table 113. Acella Pharmaceuticals Basic Information, Gabapentin Drug Manufacturing Base, Sales Area and Its Competitors

Table 114. Acella Pharmaceuticals Gabapentin Drug Product Offered

Table 115. Acella Pharmaceuticals Gabapentin Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 116. Acella Pharmaceuticals Main Business

Table 117. Acella Pharmaceuticals Latest Developments

Table 118. Taro Basic Information, Gabapentin Drug Manufacturing Base, Sales Area and Its Competitors

Table 119. Taro Gabapentin Drug Product Offered

Table 120. Taro Gabapentin Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 121. Taro Main Business

Table 122. Taro Latest Developments

Table 123. Sun Pharmaceutical Basic Information, Gabapentin Drug Manufacturing Base, Sales Area and Its Competitors

Table 124. Sun Pharmaceutical Gabapentin Drug Product Offered

Table 125. Sun Pharmaceutical Gabapentin Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 126. Sun Pharmaceutical Main Business

Table 127. Sun Pharmaceutical Latest Developments

Table 128. Glenmark Basic Information, Gabapentin Drug Manufacturing Base, Sales Area and Its Competitors

Table 129. Glenmark Gabapentin Drug Product Offered

Table 130. Glenmark Gabapentin Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 131. Glenmark Main Business

Table 132. Glenmark Latest Developments

Table 133. Amneal Pharmaceuticals Basic Information, Gabapentin Drug Manufacturing Base, Sales Area and Its Competitors

Table 134. Amneal Pharmaceuticals Gabapentin Drug Product Offered

Table 135. Amneal Pharmaceuticals Gabapentin Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 136. Amneal Pharmaceuticals Main Business

Table 137. Amneal Pharmaceuticals Latest Developments

Table 138. Aurobindo Pharma Basic Information, Gabapentin Drug Manufacturing Base, Sales Area and Its Competitors

Table 139. Aurobindo Pharma Gabapentin Drug Product Offered

Table 140. Aurobindo Pharma Gabapentin Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 141. Aurobindo Pharma Main Business

Table 142. Aurobindo Pharma Latest Developments

Table 143. Zydus Pharmaceuticals Basic Information, Gabapentin Drug Manufacturing Base, Sales Area and Its Competitors

Table 144. Zydus Pharmaceuticals Gabapentin Drug Product Offered

Table 145. Zydus Pharmaceuticals Gabapentin Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 146. Zydus Pharmaceuticals Main Business

Table 147. Zydus Pharmaceuticals Latest Developments

Table 148. Hi-Tech Pharmaceuticals Basic Information, Gabapentin Drug Manufacturing Base, Sales Area and Its Competitors

Table 149. Hi-Tech Pharmaceuticals Gabapentin Drug Product Offered

Table 150. Hi-Tech Pharmaceuticals Gabapentin Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 151. Hi-Tech Pharmaceuticals Main Business

Table 152. Hi-Tech Pharmaceuticals Latest Developments

Table 153. Marksans Pharma Basic Information, Gabapentin Drug Manufacturing Base, Sales Area and Its Competitors

Table 154. Marksans Pharma Gabapentin Drug Product Offered

Table 155. Marksans Pharma Gabapentin Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 156. Marksans Pharma Main Business

Table 157. Marksans Pharma Latest Developments

Table 158. Mylan Basic Information, Gabapentin Drug Manufacturing Base, Sales Area and Its Competitors

Table 159. Mylan Gabapentin Drug Product Offered

Table 160. Mylan Gabapentin Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 161. Mylan Main Business

Table 162. Mylan Latest Developments

Table 163. InvaGen Pharmaceuticals Basic Information, Gabapentin Drug Manufacturing Base, Sales Area and Its Competitors

Table 164. InvaGen Pharmaceuticals Gabapentin Drug Product Offered

Table 165. InvaGen Pharmaceuticals Gabapentin Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 166. InvaGen Pharmaceuticals Main Business

Table 167. InvaGen Pharmaceuticals Latest Developments

Table 168. Alkem Laboratories Basic Information, Gabapentin Drug Manufacturing Base, Sales Area and Its Competitors

Table 169. Alkem Laboratories Gabapentin Drug Product Offered

Table 170. Alkem Laboratories Gabapentin Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 171. Alkem Laboratories Main Business

Table 172. Alkem Laboratories Latest Developments

Table 173. Tris Pharma Basic Information, Gabapentin Drug Manufacturing Base, Sales Area and Its Competitors

Table 174. Tris Pharma Gabapentin Drug Product Offered

Table 175. Tris Pharma Gabapentin Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 176. Tris Pharma Main Business

Table 177. Tris Pharma Latest Developments

Table 178. ACI HealthCare Limited Basic Information, Gabapentin Drug Manufacturing Base, Sales Area and Its Competitors

Table 179. ACI HealthCare Limited Gabapentin Drug Product Offered

Table 180. ACI HealthCare Limited Gabapentin Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 181. ACI HealthCare Limited Main Business

Table 182. ACI HealthCare Limited Latest Developments

Table 183. Jiangsu Hengrui Medicine Basic Information, Gabapentin Drug Manufacturing Base, Sales Area and Its Competitors

Table 184. Jiangsu Hengrui Medicine Gabapentin Drug Product Offered

Table 185. Jiangsu Hengrui Medicine Gabapentin Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 186. Jiangsu Hengrui Medicine Main Business

Table 187. Jiangsu Hengrui Medicine Latest Developments

Table 188. CSPC Ouyi Pharmaceutical Basic Information, Gabapentin Drug Manufacturing Base, Sales Area and Its Competitors

Table 189. CSPC Ouyi Pharmaceutical Gabapentin Drug Product Offered

Table 190. CSPC Ouyi Pharmaceutical Gabapentin Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 191. CSPC Ouyi Pharmaceutical Main Business

Table 192. CSPC Ouyi Pharmaceutical Latest Developments

Table 193. Sciegen Pharmaceuticals Basic Information, Gabapentin Drug Manufacturing Base, Sales Area and Its Competitors

Table 194. Sciegen Pharmaceuticals Gabapentin Drug Product Offered

Table 195. Sciegen Pharmaceuticals Gabapentin Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 196. Sciegen Pharmaceuticals Main Business

Table 197. Sciegen Pharmaceuticals Latest Developments

Table 198. Epic Pharma Basic Information, Gabapentin Drug Manufacturing Base, Sales Area and Its Competitors

Table 199. Epic Pharma Gabapentin Drug Product Offered

Table 200. Epic Pharma Gabapentin Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 201. Epic Pharma Main Business

Table 202. Epic Pharma Latest Developments

Table 203. Lupin Limited Basic Information, Gabapentin Drug Manufacturing Base, Sales Area and Its Competitors

Table 204. Lupin Limited Gabapentin Drug Product Offered

Table 205. Lupin Limited Gabapentin Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 206. Lupin Limited Main Business

Table 207. Lupin Limited Latest Developments

List of Figures

Figure 1. Picture of Gabapentin Drug

Figure 2. Gabapentin Drug Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Gabapentin Drug Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Gabapentin Drug Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Gabapentin Drug Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Capsule

Figure 10. Product Picture of Tablet

Figure 11. Product Picture of Oral Solution

Figure 12. Global Gabapentin Drug Sales Market Share by Type in 2021

Figure 13. Global Gabapentin Drug Revenue Market Share by Type (2017-2022)

Figure 14. Gabapentin Drug Consumed in Postherpetic Neuralgia in Adults

Figure 15. Global Gabapentin Drug Market: Postherpetic Neuralgia in Adults (2017-2022) & (K Units)

Figure 16. Gabapentin Drug Consumed in Partial Onset Seizures

Figure 17. Global Gabapentin Drug Market: Partial Onset Seizures (2017-2022) & (K Units)

Figure 18. Gabapentin Drug Consumed in Others

Figure 19. Global Gabapentin Drug Market: Others (2017-2022) & (K Units)

Figure 20. Global Gabapentin Drug Sales Market Share by Application (2017-2022)

Figure 21. Global Gabapentin Drug Revenue Market Share by Application in 2021

Figure 22. Gabapentin Drug Revenue Market by Company in 2021 ($ Million)

Figure 23. Global Gabapentin Drug Revenue Market Share by Company in 2021

Figure 24. Global Gabapentin Drug Sales Market Share by Geographic Region (2017-2022)

Figure 25. Global Gabapentin Drug Revenue Market Share by Geographic Region in 2021

Figure 26. Global Gabapentin Drug Sales Market Share by Region (2017-2022)

Figure 27. Global Gabapentin Drug Revenue Market Share by Country/Region in 2021

Figure 28. Americas Gabapentin Drug Sales 2017-2022 (K Units)

Figure 29. Americas Gabapentin Drug Revenue 2017-2022 ($ Millions)

Figure 30. APAC Gabapentin Drug Sales 2017-2022 (K Units)

Figure 31. APAC Gabapentin Drug Revenue 2017-2022 ($ Millions)

Figure 32. Europe Gabapentin Drug Sales 2017-2022 (K Units)

Figure 33. Europe Gabapentin Drug Revenue 2017-2022 ($ Millions)

Figure 34. Middle East & Africa Gabapentin Drug Sales 2017-2022 (K Units)

Figure 35. Middle East & Africa Gabapentin Drug Revenue 2017-2022 ($ Millions)

Figure 36. Americas Gabapentin Drug Sales Market Share by Country in 2021

Figure 37. Americas Gabapentin Drug Revenue Market Share by Country in 2021

Figure 38. United States Gabapentin Drug Revenue Growth 2017-2022 ($ Millions)

Figure 39. Canada Gabapentin Drug Revenue Growth 2017-2022 ($ Millions)

Figure 40. Mexico Gabapentin Drug Revenue Growth 2017-2022 ($ Millions)

Figure 41. Brazil Gabapentin Drug Revenue Growth 2017-2022 ($ Millions)

Figure 42. APAC Gabapentin Drug Sales Market Share by Region in 2021

Figure 43. APAC Gabapentin Drug Revenue Market Share by Regions in 2021

Figure 44. China Gabapentin Drug Revenue Growth 2017-2022 ($ Millions)

Figure 45. Japan Gabapentin Drug Revenue Growth 2017-2022 ($ Millions)

Figure 46. South Korea Gabapentin Drug Revenue Growth 2017-2022 ($ Millions)

Figure 47. Southeast Asia Gabapentin Drug Revenue Growth 2017-2022 ($ Millions)

Figure 48. India Gabapentin Drug Revenue Growth 2017-2022 ($ Millions)

Figure 49. Australia Gabapentin Drug Revenue Growth 2017-2022 ($ Millions)

Figure 50. Europe Gabapentin Drug Sales Market Share by Country in 2021

Figure 51. Europe Gabapentin Drug Revenue Market Share by Country in 2021

Figure 52. Germany Gabapentin Drug Revenue Growth 2017-2022 ($ Millions)

Figure 53. France Gabapentin Drug Revenue Growth 2017-2022 ($ Millions)

Figure 54. UK Gabapentin Drug Revenue Growth 2017-2022 ($ Millions)

Figure 55. Italy Gabapentin Drug Revenue Growth 2017-2022 ($ Millions)

Figure 56. Russia Gabapentin Drug Revenue Growth 2017-2022 ($ Millions)

Figure 57. Middle East & Africa Gabapentin Drug Sales Market Share by Country in 2021

Figure 58. Middle East & Africa Gabapentin Drug Revenue Market Share by Country in 2021

Figure 59. Egypt Gabapentin Drug Revenue Growth 2017-2022 ($ Millions)

Figure 60. South Africa Gabapentin Drug Revenue Growth 2017-2022 ($ Millions)

Figure 61. Israel Gabapentin Drug Revenue Growth 2017-2022 ($ Millions)

Figure 62. Turkey Gabapentin Drug Revenue Growth 2017-2022 ($ Millions)

Figure 63. GCC Country Gabapentin Drug Revenue Growth 2017-2022 ($ Millions)

Figure 64. Manufacturing Cost Structure Analysis of Gabapentin Drug in 2021

Figure 65. Manufacturing Process Analysis of Gabapentin Drug

Figure 66. Industry Chain Structure of Gabapentin Drug

Figure 67. Channels of Distribution

Figure 68. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390